Home
Series of Journals
Literature
Latest literature
Popular literature
About us
Intro
Organizational structure
Editor in Chief
Copyright
Contact us
The title
The title
The keywords
The author
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University
Home
Results
The title
The title
The keywords
The author
A total of
1
result was found. Results that relate to
Shan LU
Cost-utility analysis of sacubitril/valsartan, dapagliflozin and empagliflozin in heart failure with reduced ejection fraction
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(8):878-885.
1543 times
526 times
Dan-Dan LU
Sheng-Xiang WANG
Shan LU
Dan PAN
Li-Yuan SHI
Fei-Chuang Jing2
Heart failure with reduced ejection fraction
Sacubitril/valsartan
Dapagliflozin
Empagliflozin
Markov model
Cost-utility analysis
Details
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University